Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Main conclusions and perspectives from the collective scientific assessment of the effects of plant protection products on biodiversity and ecosystem services along the land-sea continuum in France and French overseas territories.
Pesce S, Mamy L, Sanchez W, Amichot M, Artigas J, Aviron S, Barthélémy C, Beaudouin R, Bedos C, Bérard A, Berny P, Bertrand C, Bertrand C, Betoulle S, Bureau-Point E, Charles S, Chaumot A, Chauvel B, Coeurdassier M, Corio-Costet MF, Coutellec MA, Crouzet O, Doussan I, Faburé J, Fritsch C, Gallai N, Gonzalez P, Gouy V, Hedde M, Langlais A, Le Bellec F, Leboulanger C, Margoum C, Martin-Laurent F, Mongruel R, Morin S, Mougin C, Munaron D, Nélieu S, Pelosi C, Rault M, Sabater S, Stachowski-Haberkorn S, Sucré E, Thomas M, Tournebize J, Leenhardt S. Pesce S, et al. Among authors: langlais a. Environ Sci Pollut Res Int. 2023 Apr 26. doi: 10.1007/s11356-023-26952-z. Online ahead of print. Environ Sci Pollut Res Int. 2023. PMID: 37099095 Free article.
STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial.
Baptiste Oudart J, Garinet S, Leger C, Barlesi F, Mazières J, Jeannin G, Audigier-Valette C, Morot-Sibilot D, Langlais A, Amour E, Mathiot N, Birsen G, Blons H, Wislez M. Baptiste Oudart J, et al. Among authors: langlais a. Lung Cancer. 2024 Apr;190:107508. doi: 10.1016/j.lungcan.2024.107508. Epub 2024 Feb 19. Lung Cancer. 2024. PMID: 38428265 Free article. Clinical Trial.
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO).
Wislez M, Mazieres J, Lavole A, Zalcman G, Carre O, Egenod T, Caliandro R, Dubos-Arvis C, Jeannin G, Molinier O, Massiani MA, Langlais A, Morin F, Le Pimpec Barthes F, Brouchet L, Assouad J, Milleron B, Damotte D, Antoine M, Westeel V. Wislez M, et al. Among authors: langlais a. J Immunother Cancer. 2022 Oct;10(10):e005636. doi: 10.1136/jitc-2022-005636. J Immunother Cancer. 2022. PMID: 36270733 Free PMC article.
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study.
Mordant P MD, PhD, Brosseau S, Milleron B, Santelmo N, Fraboulet-Moreau S, Besse B, Langlais A, Gossot D, Thomas PA, Pujol JL, Ricordel C, Madelaine J, Lamy R, Audigier-Valette C, Missy P, Blons H, Barlesi F, Westeel V; French Cooperative Thoracic Intergroup (IFCT). Mordant P MD, PhD, et al. Among authors: langlais a. Clin Lung Cancer. 2023 Jan;24(1):1-10. doi: 10.1016/j.cllc.2022.08.013. Epub 2022 Aug 29. Clin Lung Cancer. 2023. PMID: 36180314 Free article.
49 results